ArticleThe Journal of pharmacology and experimental therapeutics2024

Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.

Daniel P Radin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.